Loading...
XSHE
002004
Market cap1.36bUSD
Dec 05, Last price  
4.86CNY
1D
0.83%
1Q
-1.02%
Jan 2017
-46.42%
IPO
318.97%
Name

Huapont Life Sciences Co Ltd

Chart & Performance

D1W1MN
XSHE:002004 chart
P/E
—
P/S
0.82
EPS
—
Div Yield, %
4.53%
Shrs. gr., 5y
-0.26%
Rev. gr., 5y
2.94%
Revenues
11.66b
+0.60%
273,504,759285,226,933492,372,337575,720,357544,520,701541,224,471638,097,6923,877,392,8154,463,630,6414,866,688,8026,174,305,6987,092,779,9749,108,900,35810,573,627,54110,091,370,48610,876,361,87312,359,182,98813,232,365,56711,594,590,41611,664,669,783
Net income
0k
-100.00%
52,499,38758,445,973206,455,18388,810,031127,684,400132,041,719305,278,505332,384,323302,449,093429,183,616636,625,439566,868,339507,905,574822,817,465931,903,068895,005,575924,961,2861,126,736,284302,122,0260
CFO
1.63b
+2.25%
43,692,33866,102,53079,208,796113,757,667123,526,89679,837,753135,225,574257,750,433349,505,047455,964,027342,447,446511,900,516591,399,5071,908,623,1262,082,144,7172,372,722,4381,269,621,9852,407,855,3431,589,476,6541,625,292,850
Dividend
Jun 03, 20240.22 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Huapont Life Sciences Co., Ltd. engages in the pharmaceutical and agrochemical businesses in China and internationally. The company is involved in the production and sale of pharmaceutical preparations and intermediates. It also offers medicines for skin, tuberculosis, anti-infection, respiratory, anti-tumor, and ophthalmology, as well as health management products. In addition, the company provides pesticide technical, intermediate and preparation products, and GLP registration technical services. The company was formerly known as Huapont-Nutrichem Co., Ltd. and changed its name to Huapont Life Sciences Co., Ltd. in September 2015. Huapont Life Sciences Co., Ltd. was founded in 2001 and is based in Chongqing, China. Huapont Life Sciences Co., Ltd. was formerly a subsidiary of Huipont Tourism Co. Ltd.
URL
http://www.huapont.com.cn/
IPO date
Jun 25, 2004
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT